---
title: "Plethico Pharmaceuticals Ltd (PLETHICO) — Share Price, Financials & Analysis"
symbol: "PLETHICO"
company: "Plethico Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/PLETHICO"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:57:12.208Z"
---

# Plethico Pharmaceuticals Ltd (PLETHICO)

Canonical page: https://tapetide.com/stocks/PLETHICO

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** plethico.com

## About

Plethico Pharmaceuticals Ltd is an India-based healthcare pharmaceutical company engaged in the manufacture and marketing of pharmaceutical and allied healthcare.

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Stock is trading at 0.02 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 9.07% over last 3 years.
- Contingent liabilities of Rs.1,518 Cr.
- Company has high debtors of 198 days.
- Company's cost of borrowing seems high

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -56% | -23% | -10% |
| revenue growth | -52% | 10% | 18% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 490 | 480 | 447 | 364 | 310 | 278 | 263 | 111 | 113 |
| Expenses | 459 | 403 | 392 | 265 | 262 | 227 | 211 | 93 | 120 |
| Operating Profit | 32 | 77 | 54 | 100 | 48 | 51 | 52 | 18 | -7 |
| OPM % | 7 | 16 | 12 | 27 | 16 | 18 | 20 | 16 | -6 |
| Other Income | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | -320 |
| Interest | 15 | 35 | 23 | 29 | 57 | 36 | 52 | 12 | 22 |
| Depreciation | 4 | 10 | 7 | 27 | 16 | 15 | 15 | 11 | 16 |
| Profit before tax | 16 | 38 | 24 | 43 | -24 | -1 | -15 | -4 | -365 |
| Tax % | 16 | -18 | 14 | -2 | -51 | 34 | -59 | 0 | -27 |
| Net Profit | 13 | 44 | 21 | 44 | -12 | -2 | -6 | -4 | -266 |
| EPS in Rs | 3.88 | 13.03 | 6.16 | 12.94 | -3.52 | -0.49 | -1.85 | -1.19 | -77.99 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2006 | Dec 2007 15m | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 15m | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 366 | 549 | 905 | 1249 | 1529 | 1557 | 1632 | 2060 | 765 |
| Expenses | 272 | 410 | 774 | 1014 | 1191 | 1342 | 1470 | 1766 | 652 |
| Operating Profit | 93 | 140 | 131 | 235 | 338 | 215 | 161 | 294 | 113 |
| OPM % | 26 | 25 | 15 | 19 | 22 | 14 | 10 | 14 | 15 |
| Other Income | 10 | 38 | 16 | 27 | -2 | 23 | 33 | 42 | -320 |
| Interest | 6 | 10 | 23 | 35 | 40 | 89 | 67 | 175 | 122 |
| Depreciation | 5 | 7 | 16 | 17 | 26 | 18 | 18 | 64 | 58 |
| Profit before tax | 92 | 161 | 109 | 210 | 269 | 131 | 109 | 97 | -386 |
| Tax % | 4 | 2 | -13 | -3 | 9 | 22 | 7 | -14 | — |
| Net Profit | 89 | 158 | 123 | 217 | 244 | 103 | 101 | 111 | -278 |
| EPS in Rs | 25.81 | 46.48 | 36.21 | 63.68 | 71.74 | 30.21 | 29.79 | 32.49 | -81.52 |
| Dividend Payout % | 10 | 5 | 7 | 4 | 3 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 |
| Reserves | 412 | 559 | 702 | 856 | 1037 | 1331 | 1333 | 1580 |
| Borrowings | 95 | 383 | 682 | 612 | 581 | 1069 | 1187 | 1391 |
| Other Liabilities | 48 | 43 | 92 | 87 | 180 | 126 | 177 | 309 |
| Total Liabilities | 588 | 1018 | 1509 | 1590 | 1832 | 2559 | 2732 | 3315 |
| Fixed Assets | 177 | 111 | 425 | 401 | 411 | 445 | 427 | 986 |
| CWIP | 24 | 2 | 191 | 213 | 255 | 401 | 395 | 0 |
| Investments | 43 | 409 | 199 | 199 | 199 | 199 | 199 | 199 |
| Other Assets | 344 | 496 | 694 | 776 | 967 | 1514 | 1711 | 2130 |
| Total Assets | 588 | 1018 | 1509 | 1590 | 1832 | 2559 | 2732 | 3315 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -39 | 70 | 138 | 165 | 176 | -272 | -61 | 244 |
| Cash from Investing Activity | -39 | -255 | -409 | -14 | -101 | -15 | 23 | -490 |
| Cash from Financing Activity | 146 | 266 | 167 | -147 | -85 | 357 | -40 | 249 |
| Net Cash Flow | 68 | 81 | -105 | 4 | -10 | 70 | -79 | 2 |
| Free Cash Flow | -65 | 67 | -248 | 152 | 91 | -373 | -56 | -386 |
| CFO/OP | -36 | 50 | 115 | 64 | 55 | -118 | -43 | 78 |

### Ratios

| Item | Sep 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 232 | 177 | 157 | 133 | 152 | 228 | 274 | 198 |
| Inventory Days | 42 | 17 | 114 | 84 | 73 | 76 | 72 | 60 |
| Days Payable | 25 | 16 | 66 | 35 | 62 | 23 | 24 | 32 |
| Cash Conversion Cycle | 249 | 177 | 205 | 181 | 163 | 281 | 322 | 225 |
| Working Capital Days | 234 | 204 | 212 | 177 | 171 | 300 | 337 | 281 |
| ROCE % | — | 20 | 17 | 17 | 20 | 14 | 7 | 10 |

## Shareholding Pattern

### annual

| Category | Jun 2016 |
| --- | --- |
| Promoters | 57.75% |
| FIIs | 2.7% |
| DIIs | 16.71% |
| Public | 22.84% |
| No. of Shareholders | 16430 |

### Quarterly

| Category | Jun 2016 |
| --- | --- |
| Promoters | 57.75% |
| FIIs | 2.7% |
| DIIs | 16.71% |
| Public | 22.84% |
| No. of Shareholders | 16430 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 8 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 173.72 | Sell |
| EMA (10) | 175.15 | Sell |
| SMA (20) | 181.39 | Sell |
| EMA (20) | 180.91 | Sell |
| SMA (50) | 196.68 | Sell |
| EMA (50) | 198.54 | Sell |
| SMA (100) | 230.82 | Sell |
| EMA (100) | 230.27 | Sell |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.93 | Neutral |
| MACD (12,26,9) | -8.01 | Sell |
| Stochastic (14,3,3) | 23.52 | Neutral |
| ADX (14) | 25.18 | Buy |
| Williams %R (14) | -59.58 | Neutral |
| ATR (14) | 10.19 | High Volatility |
| ROC (12) | -6.21 | Sell |
| Stoch RSI (14) | 79.4 | Neutral |
| UO (7,14,28) | 53.57 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| — | [Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016 22 Jul 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E1C028E6_B1A0_4589_9DC1_197F609052A0_120748.pdf) |
| — | [Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016 22 Jul 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/7/E1C028E6_B1A0_4589_9DC1_197F609052A0_120748.pdf) |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 30 Apr 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6B7EA9E0_3B5D_40F4_8A98_F99C6A5C13BB_144608.pdf) |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 30 Apr 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/4/6B7EA9E0_3B5D_40F4_8A98_F99C6A5C13BB_144608.pdf) |
| — | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 26 Apr 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57A855CE_F44A_4496_8A02_500351DA0EF4_170830.pdf) |
| — | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 26 Apr 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/4/57A855CE_F44A_4496_8A02_500351DA0EF4_170830.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_190_PLETHICO_2012_2012_01072013174557.zip) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/532739/5327390314.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/532739/5327391212.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:57:12.208Z.